不同脱细胞真皮基质用于假体乳房再造结局的荟萃分析
该荟萃分析纳入17项研究,比较FlexHD、DermaMatrix、即用型AlloDerm与冻干型AlloDerm在假体乳房再造中的术后并发症风险。结果显示三种新型人尸体皮肤源产品与冻干型AlloDerm的并发症合并风险相似,但多数研究证据等级低,需进一步研究。
要点
- FlexHD与冻干型AlloDerm的各类并发症合并风险相似
- DermaMatrix与冻干型AlloDerm的并发症合并风险无差异
- 即用型与冻干型AlloDerm的并发症合并风险无差异
核心结论
- 三种较新的人尸体皮肤源产品FlexHD、DermaMatrix和即用型AlloDerm与使用较久的冻干型AlloDerm相比,并发症风险相似。
研究设计与样本
- 荟萃分析纳入17项比较不同脱细胞真皮基质用于假体乳房再造结局的研究,其中仅1项为随机对照试验,其余16项为回顾性设计。
主要发现
- FlexHD与冻干型AlloDerm比较的荟萃分析纳入6项研究,两者各类并发症的合并风险相似。
- DermaMatrix与冻干型AlloDerm比较的荟萃分析纳入4项研究,两者并发症合并风险无差异。
- 即用型与冻干型AlloDerm比较的荟萃分析纳入4项研究,两者并发症合并风险无差异。
关键数值与推荐
- 感兴趣结局为术后并发症发生率:感染、血清肿、乳房切除皮瓣坏死、再造失败和总体并发症。
- FlexHD、DermaMatrix和即用型AlloDerm与冻干型AlloDerm的比较在多篇研究中开展,其中12项研究参与荟萃分析。
临床怎么用
- 选择脱细胞真皮基质产品时可参考本荟萃分析结果,FlexHD、DermaMatrix和即用型AlloDerm与冻干型AlloDerm并发症风险相似。
局限性
- 多数研究证据等级低,仅1项随机对照试验,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The current diversity of the available acellular dermal matrix (ADM) materials for implant-based breast reconstruction raises the issue of whether there are any differences in postoperative outcomes according to the kind of ADM used. The present meta-analysis aimed to investigate whether choice of ADM products can affect outcomes. METHODS: Studies that used multiple kinds of ADM products for implant-based breast reconstruction and compared outcomes between them were searched. Outcomes of interest were rates of postoperative complications: infection, seroma, mastectomy flap necrosis, reconstruction failure, and overall complications. RESULTS: A total of 17 studies met the selection criteria. There was only 1 randomized controlled trial, and the other 16 studies had retrospective designs. Comparison of FlexHD, DermaMatrix, and ready-to-use AlloDerm with freeze-dried AlloDerm was conducted in multiple studies and could be meta-analyzed, in which 12 studies participated. In the meta-analysis comparing FlexHD and freeze-dried AlloDerm, using the results of 6 studies, both products showed similar pooled risks for all kinds of complications. When comparing DermaMatrix and freeze-dried AlloDerm with the results from 4 studies, there were also no differences between the pooled risks of complications of the two. Similarly, the meta-analysis of 4 studies comparing ready-to-use and freeze-dried AlloDerm demonstrated that the pooled risks for the complications did not differ. CONCLUSIONS: This meta-analysis demonstrates that the 3 recently invented, human cadaveric skin-based products of FlexHD, DermaMatrix, and ready-to-use AlloDerm have similar risks of complications compared with those of freeze-dried AlloDerm, which has been used for longer. However, as most studies had low levels of evidence, further investigations are needed.
引用
- Lee KT, Mun GH. A Meta-analysis of Studies Comparing Outcomes of Diverse Acellular Dermal Matrices for Implant-Based Breast Reconstruction. Ann Plast Surg. 2017. PMID: 28509698. doi:10.1097/SAP.0000000000001085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。